News

US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...
Mitsubishi Tanabe Pharma Corporation is now under the ownership of US private investment firm Bain Capital Private Equity.
US biotech IGM Biosciences yesterday revealed it has entered into a definitive merger agreement to be acquired by Concentra ...
Artificial Intelligence (AI) is reshaping pharmacovigilance, promising faster detection of safety signals hidden within ...
California biotech Unnatural Products (UNP) announced a strategic multi-target research collaboration with Dutch immunology ...
Swiss biosimilars and generics major Sandoz has announced the start of construction for a new, state-of-the-art biosimilars ...
Sino-American antibody company Adagene (Nasdaq: ADAG) has announced a strategic investment and option exercise by Sanofi ...
Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...
Mental health company atai Life Sciences (NASDAQ: ATAI) was trading more than 31% higher during Tuesday morning’s trading in ...
Marking a new step forward in its international growth, Spanish privately-held pharma company Esteve has entered into an ...
The US Food and Drug Administration (FDA) is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD)—including certain formulations ...
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Unicycive Therapeutics’ New Drug ...